EUVIMEDEUVIMED entdecken
Crossref

Development of Ribityllumazine Analogue as Mucosal-Associated Invariant T Cell Ligands

Ryosuke Takasaki, Emi Ito, Masamichi Nagae, Yuki Takahashi iD, Takuro Matsuoka, Wakana Yasue, Norihito Arichi iD, Hiroaki Ohno iD, Sho Yamasaki, Shinsuke Inuki iD

Journal of the American Chemical Society · 2024

DOI: 10.1021/jacs.4c12997 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2024. Verfasst von Ryosuke Takasaki und 9 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Kyoto 606-8501, Japan. Hauptthemen laut MEDLINE: Mucosal-Associated Invariant T Cells. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science, Japan Science and Technology Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mucosal-Associated Invariant T CellsHumansLigandsAnimalsMiceStructure-Activity RelationshipCrystallography, X-RayModels, MolecularHistocompatibility Antigens Class IMolecular StructureRibitolUracil

Substanzen

Ligands5-(2-oxopropylideneamino)-6-d-ribitylaminouracilHistocompatibility Antigens Class IRibitolUracil

Autor:innen und Institutionen

  • Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Kyoto 606-8501, Japan.
  • Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan.
  • Immunology Frontier Research Center (IFReC), Osaka University, Suita, Osaka 565-0871, Japan.
  • Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Tokushima 770-8505, Japan.

ORCID-Profile: Yuki Takahashi, Norihito Arichi, Hiroaki Ohno, Shinsuke Inuki

Förderung

  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science
  • Japan Science and Technology Agency

Zitieren

APA

Takasaki, R., Ito, E., Nagae, M., Takahashi, Y., Matsuoka, T., Yasue, W., Arichi, N., Ohno, H., Yamasaki, S., & Inuki, S. (2024). Development of Ribityllumazine Analogue as Mucosal-Associated Invariant T Cell Ligands. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.4c12997

Vancouver

Takasaki R, Ito E, Nagae M, Takahashi Y, Matsuoka T, Yasue W, et al. Development of Ribityllumazine Analogue as Mucosal-Associated Invariant T Cell Ligands. Journal of the American Chemical Society. 2024. doi:10.1021/jacs.4c12997

BibTeX
@article{Takasaki2024,
  author = {Takasaki, Ryosuke and Ito, Emi and Nagae, Masamichi and Takahashi, Yuki and Matsuoka, Takuro and Yasue, Wakana and Arichi, Norihito and Ohno, Hiroaki and Yamasaki, Sho and Inuki, Shinsuke},
  title = {Development of Ribityllumazine Analogue as Mucosal-Associated Invariant T Cell Ligands},
  journal = {Journal of the American Chemical Society},
  year = {2024},
  doi = {10.1021/jacs.4c12997}
}
Kostenlos starten →